AGENTS FOR STIMULATING ACTIVITY OF METHYL MODIFYING ENZYMES AND METHODS OF USE THEREOF

• US 20110021362A1
• Filed: 07/20/2010
• Published: 01/27/2011
• Est. Priority Date: 07/20/2009
• Status: Abandoned Application

• Current Assignee: Constellation Pharmaceuticals Incorporated (Morphosys Ag)
• Original Assignee: Constellation Pharmaceuticals Incorporated (Morphosys Ag)
• Inventors: Lan, Fei, Trojer, Patrick
• Application Number:
  US12/839,594
• Publication Number:
  US 20110021362A1
• Time in Patent Office: Days
• US Class Current: 506/7
• CPC Class Codes: C12Q 1/26 involving oxidoreductase
• CPC Class Codes: G01N 2333/906 acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
• CPC Class Codes: G01N 2500/02 Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Abstract

Agents for stimulating activity of methyl modifying enzymes and methods of using the enzymes in assays to identify enzyme modulators are provided herein.

Claims

1. A method of evaluating a test compound, the method comprising:

contacting a histone methyl modifying enzyme and a substrate with a test compound in the presence of a stimulating agent;

evaluating activity of the histone methyl modifying enzyme on the substrate in the presence of the test compound, relative to a control, wherein a change in activity of the histone methyl modifying enzyme in the presence of the test compound, relative to the control, indicates that the test compound is a modulator of the histone methyl modifying enzyme.

3. The method of claim 1, wherein the histone methyl modifying enzyme comprises a histone methylase.

4. The method of claim 1, wherein the histone methyl modifying enzyme comprises a histone demethylase.

5. The method of claim 1, wherein the substrate is selected from the group consisting of a peptide, a histone polypeptide, a plurality of histone polypeptides, a nucleosome, an oligonucleosome.

10. The method of claim 1, wherein the stimulating agent comprises a methylated peptide.

11. The method of claim 10, wherein the methylated peptide is 4-60 amino acids in length.

12. The method of claim 10, wherein the methylated peptide comprises one or more methylated lysine residues.

13. The method of claim 12, wherein the methylated peptide comprises one or more tri-methylated lysine residues.

14. The method of claim 12, wherein the methylated peptide comprises one or more di-methylated lysine residues.

15. The method of claim 12, wherein the methylated peptide comprises one or more mono-methylated lysine residues.

18. The method of claim 10, wherein the methylated peptide comprises a methylated histone peptide selected from the group consisting of a methylated histone H3 peptide, a methylated histone H4 peptide, and a methylated histone H1 peptide.

24. The method of claim 18, wherein the methylated histone peptide comprises at least four consecutive amino acids of the following H3 histone peptide sequence:

25. The method of claim 24, wherein the H3 histone peptide is methylated on one or more of the following lysine residues:

K4, K9, K18, K27, K36, and K79.

26. The method of claim 25, wherein the H3 histone peptide is methylated on K27.

27. The method of claim 25, wherein the H3 histone peptide is methylated on K9.

28. The method of claim 18, wherein the methylated histone peptide comprises at least four consecutive amino acids of the following H4 histone peptide sequence:

29. The method of claim 28, wherein the H4 histone peptide is methylated on K20.

30. The method of claim 18, wherein the methylated histone peptide comprises at least four consecutive amino acids of the following H1 histone peptide sequence:

31. The method of claim 30, wherein the H1 histone peptide is methylated on K25.

32. The method of claim 1, wherein the stimulating agent is present in an amount which stimulates activity of the histone methyl modifying enzyme at least 2-fold.

35. The method of claim 1, wherein the test compound comprises a small molecule, a peptide, an antibody, or a nucleic acid.

36. The method of claim 1, wherein the methyl modifying enzyme and substrate are contacted with a library of test compounds, and wherein a change in activity of the methyl modifying enzyme in the presence of the library, relative to a control, indicates that the library comprises a modulator of the methyl modifying enzyme.

39. The method of claim 3, wherein the histone methylase comprises a Polycomb Repressive Complex 2 polypeptide complex.

74. The method of claim 5, wherein the plurality of histone polypeptides comprises a histone dimer, a histone tetramer, or a histone octamer.

75. The method of claim 1, wherein the stimulating agent comprises a methylated peptide, and wherein the substrate is selected from the group consisting of a peptide, a histone polypeptide, a plurality of histone polypeptides, a nucleosome, an oligonucleosome.

76. The method of claim 75, wherein the histone peptide is a methylated histone peptide.

77. The method of claim 4, wherein the histone demethylase is selected from the group consisting of GASC1, JARID1C/SMCX and PHF8.

2. (canceled)

6-9. -9. (canceled)

16-17. -17. (canceled)

19-23. -23. (canceled)

33-34. -34. (canceled)

37-38. -38. (canceled)

40. A reaction mixture comprising:

a histone methyl modifying enzyme;

a substrate; and

a stimulating agent, wherein the stimulating agent is present in an amount sufficient to increase activity of the histone methyl modifying enzyme.

41-73. -73. (canceled)